NEUCA S.A. (FRA:7HD)

Market Cap	770.90M +2.2%
Revenue (ttm)	3.22B +8.0%
Net Income	40.87M +20.1%
EPS	8.92 +19.1%
Shares Out	n/a
PE Ratio	18.86
Forward PE	15.86
Dividend	3.76 (2.28%)
Ex-Dividend Date	Jul 15, 2025

Volume	n/a
Open	162.80
Previous Close	165.20
Day's Range	162.80 - 162.80
52-Week Range	147.80 - 199.80
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	May 21, 2026

About NEUCA

NEUCA S.A. engages in the wholesale distribution of pharmaceuticals in Poland. It operates through Wholesale Distribution of Medicines, Manufacture of Pharmaceuticals, Medical Operator, Clinical Trials, and Insurance Activities segments. The company offers Rx, OTC drugs, dietary supplements, medical devices, dermocosmetics, hygiene products, personal protective equipment, as well as diagnostic and dressing materials under the Świat Zdrowia, APTEO, GENOPTIM, CERA+ Solutions, and Kic Kic brands. It also provides medical care services, including p...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 1990
• Employees: 5,339
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 7HD

Financial Performance

In 2025, NEUCA's revenue was 13.64 billion, an increase of 8.18% compared to the previous year's 12.61 billion. Earnings were 155.58 million, an increase of 0.87%.

Financial numbers in PLN